Amphetamine Extended-Release

FDA Drug Profile — Amphetamine Extended-Release

Amphetamine Extended-Release is listed in the FDA National Drug Code directory with 18 NDC codes, marketed under brand name including Amphetamine Extended-Release. Available dosage form: tablet, orally disintegrating.

Drug details

Generic Name
Amphetamine Extended-Release
Brand Names
Amphetamine Extended-Release
Application Number
NDA204326
Sponsor
Neos Therapeutics, LP
NDC Codes
18
Dosage Forms
TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients
AMPHETAMINE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.